Elidel-Study: Elidel in Patients With Atopic Dermatitis
Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function...
Brief Summary
Official Title: “Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods”
Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
- Study Primary Completion Date: March 2007
Intervention(s) in this Clinical Trial
- Drug: Elidel-Creme
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Age > 18 years
- Atopic dermatitis on both lower arms at least 1% body surface area.
- Atopic Dermatitis Severity Index (ADSI)-Score >= 6
- Investigator Global Assessment (IGA)-Score >= 2
Exclusion Criteria:
- Systemic therapy with immunosuppressive drugs within the past 24 weeks
- Phototherapy against atopic dermatitis.
- Antibiotic therapy against atopic dermatitis.
- Allergy against Elidel.
- Pregnancy
- Nursing
- Skin cancer
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Dresden University of Technology Other
Overall Clinical Trial Officials and Contacts
Roland Aschoff, MD Principal Investigator Department of Dermatology. Medical Faculty, Technical University Dresden, Germany
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00180141
Study ID Number: CASM981CDE16
ClinicalTrials.gov Identifier: NCT00180141
Health Authority: Germany: Federal Institute for Drugs and Medical Devices
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00180141
